07/17/2024
Big News! Goldfinch Health and Pain Care Labs have just announced an exciting new partnership to tackle opioid misuse and revolutionize post-surgical recovery with pre-op opioid prevention strategies.
With 60% of post-surgical opioids left unused, often leading to teen experimentation and addiction, this collaboration aims to make a significant impact. Goldfinch Health and Pain Care Labs will provide FDA-approved pain relief and evidence-based support before surgery to prevent opioid use disorder (OUD).
Dr. Amy Baxter, founder and CEO of Pain Care Labs, emphasized, "The opioid crisis continues to devastate communities. With half-used bottles of post-surgical opioids in every home, we must stop the pill flow. Goldfinch's program is crucial to provide physical pain management, opioid disposal solutions, and comprehensive patient support."
This proactive approach includes educating patients about effective non-opioid pain management tools like VibraCool® before surgery, reducing the need for opioids at home and cutting down on the number of unused pills.
John Greenwood, COO of Goldfinch Health, added, "If every patient had access to these tools and knowledge, we could prevent one billion leftover pills from potential misuse. By combining our expertise with Pain Care Labs' innovative technology, we're creating a powerful tool to cut the flow of opioids fueling new dependencies."
Learn more about how this dynamic partnership is transforming pain management and reducing the risk of opioid addiction following surgery by visiting https://zurl.co/4rRV .
Together, we're making a difference! 🌟
Innovative Partnership Disrupts Post-Surgical Recovery with Pre-op Opioid Prevention